CTOs on the Move

Respicardia

www.respicardia.com

 
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia® is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve Respiratory Rhythm Management and cardiovascular health. The remedē® System is an innovative implantable stimulation device designed to restore natural breathing during sleep for patients with Central Sleep Apnea.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.respicardia.com
  • 12400 Whitewater Dr Suite 150
    Minnetonka, MN USA 55343
  • Phone: 952.540.4470

Executives

Name Title Contact Details

Funding

Respicardia raised $58.5M on 12/19/2017

Similar Companies

Velano Vascular

Velano Vascular aims to improve the hospital experience by reducing the pain, anxiety, and inefficiencies of blood draws.

Accelmed Growth Partners

Accelmed is an investment firm focused on value creation for medical device companies and technologies. Accelmed was founded in 2009 by Mori Arkin and Uri Geiger and invests in small and mid-cap private and public companies.

Cassling

Cassling is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nevro

Nevro`s Senza system is the only SCS system capable of delivering HF10™ therapy and providing pain relief without paresthesia.

Fukuda Denshi

Fukuda Denshi is a Redmond, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.